| Product Name | Bevacizumab (anti-VEGF) | RhuMab VEGF |
|---|---|
| CAS | 216974-75-3 |
| MW | 149 kDa |
| Storage condition | Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 1 mg | 3-5days | ¥1500.00 | Visible after login | |
| 5 mg | 3-5days | ¥6000.00 | Visible after login | |
| 10 mg | 3-5days | ¥12000.00 | Visible after login | |
| 50 mg | 3-5days | ¥48000.00 | Visible after login | |
| 100 mg | 3-5days | ¥768000.00 | Visible after login |
| Product Name | Bevacizumab (anti-VEGF) | RhuMab VEGF |
|---|---|
| CAS | 216974-75-3 |
| MW | 149 kDa |
| Storage condition | Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles |
Bevacizumab (anti-VEGF, Avastin) is a humanized anti-VEGF monoclonal antibody which binds to and neutralizes all human VEGF-A isoforms and bioactive proteolytic fragments, MW:149 KD.